Skip to main content

Community Benefit

By Jeff Lagasse | 10:55 am | February 09, 2024
GSK's offering will be the first RSV vaccine available for adults ages 50-59 if approved by the FDA.
By Jeff Lagasse | 11:16 am | February 08, 2024
The goal is to ensure older adults can continue to receive services and supports in their homes, ACL said.
By Jeff Lagasse | 12:11 pm | February 07, 2024
The agency wants to modernize matching technology and reduce inequities in the waitlist process.
By Jeff Lagasse | 03:40 pm | February 05, 2024
The center will provide services including preventive and primary care, onsite pharmacy dispensing and mental health services.
By Jeff Lagasse | 11:50 am | February 01, 2024
The model is designed to improve outcomes, increase access to therapies and lower healthcare costs for vulnerable populations.
By Jeff Lagasse | 11:20 am | January 31, 2024
Paxlovid prescribed after March 8 will have a new designation not linked to emergency use authorization.
By Jeff Lagasse | 03:34 pm | January 30, 2024
New facilities in North Carolina, Louisiana and existing markets will crop up throughout the rest of this year, the company says.
By Jeff Lagasse | 10:52 am | January 30, 2024
Paramount will continue to offer its health plans, with no immediate change to how current members do business with either company.
By Jeff Lagasse | 03:23 pm | January 29, 2024
The letter urges all state Medicaid administrators to review their current policies to ensure they're in line with ADA requirements.
By Jeff Lagasse | 11:00 am | January 29, 2024
The new program paves the way toward high school equivalency and will offer assistance with career and college planning.